{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:13Z","timestamp":1792788133294,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007707","name":"University of California Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.coi.2026.102857","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:20:03Z","timestamp":1792718403000},"page":"102857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antimitochondrial antibodies in rheumatic diseases: beyond primary biliary cholangitis"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-0844","authenticated-orcid":false,"given":"Joz\u00e9lio Freire","family":"De Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1367-6782","authenticated-orcid":false,"given":"Carlos Ewerton Maia","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-0280","authenticated-orcid":false,"given":"Kirla Wagner Poti","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3442-9724","authenticated-orcid":false,"given":"Kelly Leite Maia","family":"de Messias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj","family":"Timilsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5245-2680","authenticated-orcid":false,"given":"M Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102857_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2007-1007183","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis","volume":"17","author":"Leung","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.coi.2026.102857_bib2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0016-5085(91)80033-6","article-title":"Primary biliary cirrhosis: paradigm or paradox for autoimmunity","volume":"100","author":"Gershwin","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coi.2026.102857_bib3","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coi.2026.102857_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/jaut.1994.1030","article-title":"The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens","volume":"7","author":"Whyte","year":"1994","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2026.102857_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64976-8","article-title":"Long-term outcomes in patients with primary biliary cholangitis complicated with CREST syndrome","volume":"14","author":"Abe","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2026.102857_sbref6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/cei\/uxad012","article-title":"Systemic sclerosis and primary biliary cholangitis share an antibody population with identical specificity","volume":"212","author":"Favoino","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib7","article-title":"Systemic sclerosis and primary biliary cholangitis: a comprehensive review of two overlapping rare entities with insights on diagnostics and management","volume":"17","author":"Thakkar","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.coi.2026.102857_sbref8","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1038\/s41598-019-40900-3","article-title":"Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations","volume":"9","author":"Becker","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2026.102857_bib9","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3389\/fimmu.2019.01026","article-title":"Autoantibodies in systemic lupus erythematosus target mitochondrial RNA","volume":"10","author":"Becker","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nri.2017.21","article-title":"Mitochondrial DNA in innate immune responses and inflammatory pathology","volume":"17","author":"West","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2026.102857_sbref11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/art.42428","article-title":"Prediction of erosive disease development by antimitochondrial antibodies in rheumatoid arthritis","volume":"75","author":"Moore","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_bib12","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s10067-025-07439-3","article-title":"Anti-mitochondrial antibody-positive inflammatory myopathy with multiple arrhythmias resistant to high-dose glucocorticoids and intravenous cyclophosphamide: a case-based review","volume":"44","author":"Mutoh","year":"2025","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2017.10.001","article-title":"Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis","volume":"452","author":"Ceribelli","year":"2018","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.coi.2026.102857_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.semarthrit.2017.06.004","article-title":"Inflammatory myopathy associated with anti-mitochondrial antibodies: a distinct phenotype with cardiac involvement","volume":"47","author":"Albayda","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102857_sbref15","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1007\/s10067-021-05730-7","article-title":"Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis","volume":"40","author":"Sabbagh","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_bib16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1515\/cclm-2019-0655","article-title":"Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients","volume":"58","author":"Florin","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.coi.2026.102857_bib17","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3899\/jrheum.110167","article-title":"Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis","volume":"38","author":"Cavazzana","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_bib18","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3899\/jrheum.090340","article-title":"Pet al. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients","volume":"36","author":"Assassi","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.coi.2026.102857_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/BOR.0000000000001127","article-title":"A comprehensive review of systemic sclerosis-primary biliary cholangitis overlap: emerging evidence for a distinct clinical subtype","volume":"37","author":"Memon","year":"2025","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_sbref21","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.ard.2025.06.2119","article-title":"Antimitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility","volume":"84","author":"McMahan","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102857_sbref22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ard.2025.11.007","article-title":"Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality","volume":"85","author":"Becker","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102857_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108349","article-title":"The binding of SLE autoantibodies to mitochondria","volume":"212","author":"Pisetsky","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib24","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1002\/art.39296","article-title":"Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin","volume":"67","author":"Wang","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2005.08.009","article-title":"Increased serum aminotransferases associated with anti-mitochondrial antibodies in systemic lupus erythematosus patients with autoimmune liver disease","volume":"365","author":"Li","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.coi.2026.102857_bib26","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/art.42082","article-title":"Identification of mitofusin 1 and complement component 1q subcomponent binding protein as mitochondrial targets in systemic lupus erythematosus","volume":"74","author":"Becker","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_sbref27","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1093\/rheumatology\/keaf275","article-title":"Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort study","volume":"64","author":"Barguil Mac\u00eado","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2026.102857_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102857_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.20151876","article-title":"Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus","volume":"213","author":"Caielli","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2026.102857_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.822996","article-title":"Antigen reactivity and clinical significance of autoantibodies directed against the pyruvate dehydrogenase antigen complex in patients with connective tissue disease","volume":"13","author":"Ceribelli","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12016-021-08904-y","article-title":"Antimitochondrial Antibodies: from Bench to Bedside","volume":"63","author":"Colapietro","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cei\/uxac107","article-title":"Mitochondria as disease-relevant organelles in rheumatoid arthritis","volume":"211","author":"Weyand","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.it.2025.08.003","article-title":"Mitochondrial dysfunction in myeloid cells: a central deficit in autoimmune diseases","volume":"46","author":"Kwong","year":"2025","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224632","article-title":"Mitochondrial dysfunction in rheumatoid arthritis: a comprehensive analysis by integrating gene expression, protein-protein interactions and gene ontology data","volume":"14","author":"Panga","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2026.102857_bib35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10067-005-0059-3","article-title":"Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sj\u00f6gren's syndrome: prevalence and clinical significance in 335 patients","volume":"25","author":"Nardi","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_bib36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0168-8278(94)80007-3","article-title":"Autoimmune liver disease in patients with primary Sj\u00f6gren's syndrome","volume":"20","author":"Lindgren","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.coi.2026.102857_bib37","first-page":"1453","article-title":"Sj\u00f6gren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases","volume":"17","author":"Fujikura","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0322845","article-title":"Clinical manifestations and immune correlations in anti-centromere antibody-positive and anti-SSA\/Ro antibody-positive primary Sj\u00f6gren's syndrome: a retrospective analysis","volume":"20","author":"Zou","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2026.102857_bib39","article-title":"Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sj\u00f6gren syndrome with subsequent autoimmune hemolytic anemia: a case report","volume":"99","author":"Zhao","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.coi.2026.102857_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40744-017-0074-2","article-title":"Chronic autoimmune epithelitis in Sj\u00f6gren's syndrome and primary biliary cholangitis: a comprehensive review","volume":"4","author":"Selmi","year":"2017","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.coi.2026.102857_sbref41","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100746","article-title":"Prevalence and impact of Sj\u00f6gren's syndrome in primary biliary cholangitis: a systematic review and meta-analysis","volume":"27","author":"Deng","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.coi.2026.102857_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5152\/tjg.2014.5794","article-title":"Evaluation of patients with positive anti-mitochondrial antibody in laboratory conditions","volume":"25","author":"Olt","year":"2014","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.coi.2026.102857_bib43","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.semarthrit.2021.05.019","article-title":"Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody","volume":"51","author":"Zhang","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102857_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120391","article-title":"Clinical features of anti-mitochondrial M2 antibody-positive myositis: case series of 17 patients","volume":"442","author":"Nagai","year":"2022","journal-title":"J Neurol Sci"},{"issue":"Pt 6","key":"10.1016\/j.coi.2026.102857_bib45","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/brain\/aws106","article-title":"Inflammatory myopathies associated with anti-mitochondrial antibodies","volume":"135","author":"Maeda","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.coi.2026.102857_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2018.11.004","article-title":"Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: clinical features and treatment outcomes in a Chinese cohort","volume":"29","author":"Hou","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.coi.2026.102857_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mus.27741","article-title":"Granulomatous myopathy: sarcoidosis and beyond","volume":"67","author":"Chompoopong","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.coi.2026.102857_bib48","first-page":"536","article-title":"Manifestations articulaires et syst\u00e9miques associ\u00e9es aux anticorps anti-mitochondries de type 2 [Joint and systemic manifestations related to type 2 anti-mitochondrial antibodies]","volume":"146","author":"Dh\u00f4te","year":"1995","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.coi.2026.102857_bib49","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2169\/internalmedicine.40.1104","article-title":"An autopsy case of primary biliary cirrhosis with severe interstitial pneumonia","volume":"40","author":"Hiraoka","year":"2001","journal-title":"Intern Med"},{"key":"10.1016\/j.coi.2026.102857_bib50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5114\/ceji.2016.60993","article-title":"Liver damage in primary biliary cirrhosis and accompanied by primary Sjogren\u2019s syndrome: a retrospective pilot study","volume":"41","author":"Zhu","year":"2016","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib51","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(24)01303-5","article-title":"Primary biliary cholangitis","volume":"404","author":"Tanaka","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2026.102857_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37095-z","article-title":"Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies","volume":"13","author":"Campos-Murguia","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2026.102857_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108749","article-title":"Detection of anti-mitochondrial 2-oxoacid dehydrogenase complex subunit's antibodies for the diagnosis of Primary Biliary Cholangitis","volume":"268","author":"Poyatos","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib54","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41584-022-00834-z","article-title":"The role of mitochondria in rheumatic diseases","volume":"18","author":"Becker","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cei.13512","article-title":"Autoantibodies associated with primary biliary cholangitis are common among patients with systemic lupus erythematosus even in the absence of elevated liver enzymes","volume":"203","author":"Ahmad","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib56","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1136\/annrheumdis-2013-203794","article-title":"HRES-1\/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE","volume":"73","author":"Caza","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102857_bib57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.autrev.2008.07.041","article-title":"Metabolic control of T cell activation and death in SLE","volume":"8","author":"Fernandez","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2026.102857_bib58","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.4049\/jimmunol.0901533","article-title":"Human TCR-alpha beta+ CD4- CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype","volume":"183","author":"Crisp\u00edn","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib59","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","article-title":"Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus","volume":"192","author":"Kato","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2026.102857_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.imlet.2022.03.008","article-title":"Metabolic regulation of follicular helper T cell differentiation in a mouse model of lupus","volume":"247","author":"Zou","year":"2022","journal-title":"Immunol Lett"},{"key":"10.1016\/j.coi.2026.102857_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2026.153060","article-title":"Childhood-onset versus adult-onset Sj\u00f6gren Syndrome: clinical phenotype, disease activity, and predictors of organ damage in a national multicenter cohort","volume":"80","author":"Kilic Konte","year":"2026","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102857_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.55563\/clinexprheumatol\/vxe6h0","article-title":"Differences in presentation between paediatric- and adult-onset primary Sj\u00f6gren's syndrome patients","volume":"39","author":"Legger","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_bib63","first-page":"2373","article-title":"Distinct clinical phenotypes of primary Sj\u00f6gren's syndrome differ by onset age: a retrospective study of 742 cases and review of the literature","volume":"40","author":"Luo","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2026.102857_bib64","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/rheumatology\/keab032","article-title":"Childhood-onset of primary Sj\u00f6gren's syndrome: phenotypic characterization at diagnosis of 158 children","volume":"60","author":"Ramos-Casals","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2026.102857_bib65","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3390\/jcm15062199","article-title":"Pediatric Sj\u00f6gren disease: clinical features, diagnostic challenges, and outcomes in a single-centre romanian case series","volume":"15","author":"Sparchez","year":"2026","journal-title":"J Clin Med"},{"key":"10.1016\/j.coi.2026.102857_bib66","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/jcm11041089","article-title":"Celiac disease in juvenile idiopathic arthritis and other pediatric rheumatic disorders","volume":"11","author":"Poddighe","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.coi.2026.102857_bib67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12969-023-00802-1","article-title":"Juvenile idiopathic arthritis patients with positive family history of autoimmune thyroid disease might benefit from serological screening: analysis of the international Pharmachild registry","volume":"21","author":"van Straalen","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.coi.2026.102857_sbref68","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00393-022-01216-2","article-title":"Associations between anti-mitochondrial antibodies and cardiac involvement in idiopathic inflammatory myopathy patients: a systematic review and meta-analysis","volume":"83","author":"Wang","year":"2024","journal-title":"Z Rheumatol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526001342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526001342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:24:13Z","timestamp":1792787053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526001342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":68,"alternative-id":["S0952791526001342"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102857","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimitochondrial antibodies in rheumatic diseases: beyond primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102857"}}